Women presenting to Washington Hospital Center with fetal loss would be offered participation in the study. The objective is to determine if ccffDNA obtained from maternal blood is present in the setting of missed abortion or fetal demise. The investigators primary hypothesis is that cell free fetal DNA will be present in maternal blood in the presence of a failed pregnancy.
Study Type
OBSERVATIONAL
Enrollment
50
Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
The Presence or Absence of Cell Free Fetal DNA in Maternal Blood in the Setting of a Failed Pregnancy.
Percentage of participants with the presence of cell free fetal DNA in maternal circulation after miscarriage of intrauterine fetal demise
Time frame: During initial presentation for treatment
The Accuracy of ccffDNA Compared to Genetic Information Obtained From Amniocentesis, Chorionic Villus Sampling, Fetal, or Placental Tissue.
Time frame: 3-4 weeks after specimen processing
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.